FATTY LIVER DISEASE, NONALCOHOLIC
Clinical trials for FATTY LIVER DISEASE, NONALCOHOLIC explained in plain language.
Never miss a new study
Get alerted when new FATTY LIVER DISEASE, NONALCOHOLIC trials appear
Sign up with your email to follow new studies for FATTY LIVER DISEASE, NONALCOHOLIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old heart drug could be new hope for millions with fatty liver
Disease control Recruiting nowThis study is testing if digoxin, a medication used for heart conditions, can help treat a serious liver disease called NASH (now called MASH). Researchers will give 144 people with NASH either digoxin or a placebo pill daily for 24 weeks to see if it reduces liver inflammation a…
Matched conditions: FATTY LIVER DISEASE, NONALCOHOLIC
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Could a quick scan replace an MRI for liver health?
Diagnosis Recruiting nowThis study is testing a new ultrasound device designed to measure how much fat is in your liver. Researchers want to see if this simpler, more accessible scanner gives results as accurate as the current gold-standard MRI test. Participants will get both scans to compare the measu…
Matched conditions: FATTY LIVER DISEASE, NONALCOHOLIC
Sponsor: Endra Lifesciences • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC